Expertise in
3
conditions

Aristeidis Chaidos

London, ENG, GB 
Expertise in
3
conditions
London, ENG, GB 

Overview

Aristeidis Chaidos practices practicing medicine in London, United Kingdom.

Chaidos is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Multiple Myeloma, Aase Syndrome, Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 2 clinical trials.

Locations

London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pom/Dex (Pomalidomide plus Low Dose Dexamethasone)
Study Phase: Phase 3
A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
Enrollment Status: Active_not_recruiting
Publish Date: June 12, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pomalidomide, Dexamethasone, Bortezomib
Study Phase: Phase 3
View 1 Less Clinical Trial

45 Total Publications

CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.
CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.
Journal: Blood
Published: February 04, 2026

Frequently Asked Questions about Aristeidis Chaidos

Is Aristeidis Chaidos a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Aristeidis Chaidos is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Aristeidis Chaidos participate in research or clinical trials?

Yes. Aristeidis Chaidos has published 45 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Aristeidis Chaidos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chaidos's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile